Skip to main content

Table 1 Baseline demographics for 16,023 kidney transplant recipients recorded in the ANZDATA registry from 1985 to 2013

From: Recurrent glomerulonephritis following renal transplantation and impact on graft survival

 

IgA

MCGN

MN

FSGS

Other GN

Total GN

Non-GN

P value

Number (% of Total GN)

2393 (33.07%)

348 (4.81%)

309 (4.27%)

975 (13.47%)

3211 (44.38%)

7236

8787

 

Age (years) Median (IQR)

45 (36–54)

40 (29–51)

49 (38–58)

43 (32–55)

44 (32–55)

44 (33–54)

47 (33–56)

< 0.001

Male gender

1815 (75.8%)

200 (57.5%)

235 (76.1%)

651 (66.8%)

1891 (58.9%)

4792 (66.2%)

4967 (56.5%)

< 0.001

Caucasian Ethnicity (%)

1889 (78.9%)

286 (82.1%)

274 (88.7%)

839 (86.1%)

2584 (80.5%)

5872 (81.1%)

7667 (87.2%)

< 0.001

Graft Number

       

< 0.001

Primary graft

2162 (90.35%)

288 (82.76%)

278 (89.97%)

861 (88.61%)

2886 (89.88%)

6475 (89.5%)

8096 (92.14%)

 

Secondary

215 (8.98%)

55 (15.80%)

30 (9.71%)

98 (10.05%)

288 (8.97%)

686 (9.5%)

629 (7.16%)

 

Subsequent

16 (0.67%)

5 (1.44%)

1 (0.32%)

16 (1.64%)

37 (1.15%)

75 (1%)

62 (0.71%)

 

Donor Category

       

< 0.001

Deceased donor

1552 (64.9%)

260 (74.7%)

210 (68.0%)

671 (68.8%)

2263 (70.5%)

4956 (68.5%)

6201 (70.6%)

 

Live related donor

557 (23.2%)

57 (16.4%)

71 (23.0%)

207 (21.2%)

684 (21.3%)

1576 (21.8%)

1686 (19.2%)

 

Live unrelated donor

284 (11.9%)

31 (8.9%)

28 (9.1%)

97 (9.9%)

264 (8.2%)

704 (9.7%)

900 (10.2%)

 

DM as comorbidity (% of Total GN)

73 (3.1%)

18 (5.2%)

15 (4.9%)

57 (5.8%)

103 (3.2%)

266 (3.7%)

1938 (22.1%)

< 0.001

Peak panel reactive antibodies (%) Median (IQR)

3 (0–14)

5 (0–29)

3 (0–16)

3 (0–21)

4 (0–25)

3 (0–20)

3 (0–16)

< 0.001

Total ischaemic time in hours (Median (IQR))

10 (3–15)

13 (4–19)

11 (3–16)

11 (3–16)

12 (4–17)

11 (3–16)

11 (4–16)

< 0.001

Zero HLA mismatches n(%)

179 (7.5%)

25 (7.2%)

21 (6.8%)

63 (6.5%)

245 (7.7%)

534 (7.4%)

597 (6.8%)

0.55